KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

NovoCure (NVCR) Other Gross PP&E Adjustments (2016 - 2025)

NovoCure (NVCR) has disclosed Other Gross PP&E Adjustments for 12 consecutive years, with $48.3 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 2.03% to $48.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $48.3 million through Dec 2025, up 2.03% year-over-year, with the annual reading at $48.3 million for FY2025, 2.03% up from the prior year.
  • Other Gross PP&E Adjustments hit $48.3 million in Q4 2025 for NovoCure, up from -$48.4 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $48.3 million in Q4 2025 to a low of -$48.5 million in Q1 2025.
  • Historically, Other Gross PP&E Adjustments has averaged -$15.7 million across 5 years, with a median of -$19.7 million in 2022.
  • Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 347.62% in 2023 and later tumbled 70.85% in 2025.
  • Year by year, Other Gross PP&E Adjustments stood at $876000.0 in 2021, then surged by 205.14% to $2.7 million in 2022, then soared by 347.62% to $12.0 million in 2023, then surged by 295.99% to $47.4 million in 2024, then increased by 2.03% to $48.3 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for NVCR at $48.3 million in Q4 2025, -$48.4 million in Q3 2025, and -$48.1 million in Q2 2025.